Drug Approval | October 31, 2022
USFDA issues Form-483 for Lupin's Nagpur Unit-2
The company is committed to addressing the observations at the earliest, and gaining approval for injectable manufacturing for the US
The company is committed to addressing the observations at the earliest, and gaining approval for injectable manufacturing for the US
The observation is procedural in nature and the company will address the observation within stipulated timelines.
Submission based on QuANTUM-First results showing quizartinib plus chemotherapy significantly improved overall survival compared to chemotherapy alone
Around 62% of the revenues came from the domestic market and 38% from the exports market for Q2 FY23 for a standalone business
NABH shall encourage and provide assistance in onboarding their accredited/certified facilities on ABDM’s Health Facility Registry
Since FY 2020 till FY 2022, the organisation has reduced energy consumption by 9.2%
The Bulk Drug Park is expected to attract investment of around Rs. 10,000 crore and provide employment to more than 20,000 people
The MoU will enable both countries to promote research collaboration and building capacities in the field of the Indian Ayurvedic system of traditional medicines
The two overhead tanks commissioned at a cost of Rs 57 lakh will be maintained by the village panchayats.
Mandaviya felicitated voluntary blood donors and states/UTs that have done exemplary work
Subscribe To Our Newsletter & Stay Updated
